217 related articles for article (PubMed ID: 21408163)
1. Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.
Benlahrech A; Gotch F; Kelleher P; Patterson S
PLoS One; 2011 Mar; 6(3):e17525. PubMed ID: 21408163
[TBL] [Abstract][Full Text] [Related]
2. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.
Conry SJ; Milkovich KA; Yonkers NL; Rodriguez B; Bernstein HB; Asaad R; Heinzel FP; Tary-Lehmann M; Lederman MM; Anthony DD
J Virol; 2009 Nov; 83(21):11175-87. PubMed ID: 19692459
[TBL] [Abstract][Full Text] [Related]
3. Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
Chehimi J; Azzoni L; Farabaugh M; Creer SA; Tomescu C; Hancock A; Mackiewicz A; D'Alessandro L; Ghanekar S; Foulkes AS; Mounzer K; Kostman J; Montaner LJ
J Immunol; 2007 Aug; 179(4):2642-50. PubMed ID: 17675528
[TBL] [Abstract][Full Text] [Related]
4. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections.
Vogel K; Thomann S; Vogel B; Schuster P; Schmidt B
Immunology; 2014 Dec; 143(4):588-600. PubMed ID: 24943264
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
Zhang S; Saha B; Kodys K; Szabo G
J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
[TBL] [Abstract][Full Text] [Related]
6. Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.
Tomescu C; Duh FM; Lanier MA; Kapalko A; Mounzer KC; Martin MP; Carrington M; Metzger DS; Montaner LJ
AIDS; 2010 Sep; 24(14):2151-60. PubMed ID: 20647906
[TBL] [Abstract][Full Text] [Related]
7. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
[TBL] [Abstract][Full Text] [Related]
8. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells.
Alter G; Suscovich TJ; Teigen N; Meier A; Streeck H; Brander C; Altfeld M
J Immunol; 2007 Jun; 178(12):7658-66. PubMed ID: 17548602
[TBL] [Abstract][Full Text] [Related]
9. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
Tomescu C; Chehimi J; Maino VC; Montaner LJ
J Immunol; 2007 Aug; 179(4):2097-104. PubMed ID: 17675468
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
[TBL] [Abstract][Full Text] [Related]
11. Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infection.
Tjwa ET; van Oord GW; Biesta PJ; Boonstra A; Janssen HL; Woltman AM
J Virol; 2012 Apr; 86(8):4102-9. PubMed ID: 22318141
[TBL] [Abstract][Full Text] [Related]
12. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells.
Scott-Algara D; Arnold V; Didier C; Kattan T; Pirozzi G; Barré-Sinoussi F; Pancino G
PLoS One; 2008 Apr; 3(4):e1975. PubMed ID: 18398485
[TBL] [Abstract][Full Text] [Related]
13. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
[TBL] [Abstract][Full Text] [Related]
14. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.
Chehimi J; Campbell DE; Azzoni L; Bacheller D; Papasavvas E; Jerandi G; Mounzer K; Kostman J; Trinchieri G; Montaner LJ
J Immunol; 2002 May; 168(9):4796-801. PubMed ID: 11971031
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.
Benlahrech A; Yasmin A; Westrop SJ; Coleman A; Herasimtschuk A; Page E; Kelleher P; Gotch F; Imami N; Patterson S
Clin Exp Immunol; 2012 Nov; 170(2):212-21. PubMed ID: 23039892
[TBL] [Abstract][Full Text] [Related]
16. Isoflavones, genistein and daidzein, regulate mucosal immune response by suppressing dendritic cell function.
Wei J; Bhatt S; Chang LM; Sampson HA; Masilamani M
PLoS One; 2012; 7(10):e47979. PubMed ID: 23110148
[TBL] [Abstract][Full Text] [Related]
17. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
18. Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.
Yonkers NL; Milkovich KA; Rodriguez B; Post AB; Asaad R; Heinzel FP; Valdez H; Tary-Lehmann M; Anthony DD
Clin Immunol; 2009 May; 131(2):288-97. PubMed ID: 19196551
[TBL] [Abstract][Full Text] [Related]
19. Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.
Reitano KN; Kottilil S; Gille CM; Zhang X; Yan M; O'Shea MA; Roby G; Hallahan CW; Yang J; Lempicki RA; Arthos J; Fauci AS
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):1029-37. PubMed ID: 19795986
[TBL] [Abstract][Full Text] [Related]
20. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
